Literature DB >> 31478163

The tendency of reduced periodontal destruction in acromegalic patients showing similar inflammatory status with periodontitis patients.

Yesim Ozdemir1, H Gencay Keceli2, Nafiye Helvaci3, Tomris Erbas3, Rahime M Nohutcu1.   

Abstract

PURPOSE: Evaluate periodontal status of acromegalics through clinical and biochemical variables.
METHODS: Demographics, hormone and metabolic variables, periodontal variables, gingival crevicular fluid (GCF) volume, and content data were collected from 30 patients with acromegaly, 30 patients with periodontitis, and 20 healthy subjects and comparatively analyzed.
RESULTS: GH differences between acromegaly (2.56 ± 4.86) and periodontitis (0.53 ± 0.95) (p < 0.001) were statistically significant. IGF-1 was lowest at periodontitis (113.31 ± 45.01) and lower (152.11 ± 45.56) at healthy group compared with acromegalics (220.38 ± 167.62) (p < 0.05). GH and IGF-1 had positive correlation (p < 0.05). IGF-1 and CAL had negative (p < 0.01) correlation except healthy group that showed the same correlation at the opposite direction (p < 0.05). Besides similar plaque and gingival indices with periodontitis, acromegalics showed relatively less CAL and GCF volume but except CAL, all their periodontal variables were higher than healthy subjects. GCF GH and prolactin showed higher values in acromegalics while healthy subjects showed relatively high interleukin-1, -10 and carboxyterminal telopeptide of type I collagen compared with others.
CONCLUSION: Acromegalics have a tendency of slowed periodontal destruction with an influence of GH and IGF-1 to the inflammation- and collage metabolism-related mechanisms rather than bone-associated ones. However, this information must be confirmed with further studies exploring the mechanisms possibly bonded to others.

Entities:  

Keywords:  Acromegaly; Bone loss; Gingival crevicular fluid; Growth hormone; Insulin-like growth factor-1; Periodontal

Mesh:

Substances:

Year:  2019        PMID: 31478163     DOI: 10.1007/s12020-019-02060-2

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  41 in total

Review 1.  Molecular targets in pituitary tumours.

Authors:  Anthony P Heaney; Shlomo Melmed
Journal:  Nat Rev Cancer       Date:  2004-04       Impact factor: 60.716

2.  The metabolic profile in active acromegaly is gender-specific.

Authors:  A Ciresi; M C Amato; R Pivonello; E Nazzari; L F Grasso; F Minuto; D Ferone; A Colao; C Giordano
Journal:  J Clin Endocrinol Metab       Date:  2012-11-15       Impact factor: 5.958

Review 3.  Acromegaly: clinical features at diagnosis.

Authors:  Lucio Vilar; Clarice Freitas Vilar; Ruy Lyra; Raissa Lyra; Luciana A Naves
Journal:  Pituitary       Date:  2017-02       Impact factor: 4.107

4.  Evaluation of thyroid diseases and differentiated thyroid cancer in acromegalic patients.

Authors:  Serkan Dogan; Aysegul Atmaca; Selcuk Dagdelen; Belkis Erbas; Tomris Erbas
Journal:  Endocrine       Date:  2013-05-14       Impact factor: 3.633

5.  Mortality in acromegaly: a 20-year follow-up study.

Authors:  Elina Ritvonen; Eliisa Löyttyniemi; Pia Jaatinen; Tapani Ebeling; Leena Moilanen; Pirjo Nuutila; Ritva Kauppinen-Mäkelin; Camilla Schalin-Jäntti
Journal:  Endocr Relat Cancer       Date:  2016-05-16       Impact factor: 5.678

6.  Factors influencing mortality in acromegaly.

Authors:  Ian M Holdaway; Raja C Rajasoorya; Greg D Gamble
Journal:  J Clin Endocrinol Metab       Date:  2004-02       Impact factor: 5.958

Review 7.  Systemic complications of acromegaly: epidemiology, pathogenesis, and management.

Authors:  Annamaria Colao; Diego Ferone; Paolo Marzullo; Gaetano Lombardi
Journal:  Endocr Rev       Date:  2004-02       Impact factor: 19.871

Review 8.  Guidelines for acromegaly management: an update.

Authors:  S Melmed; A Colao; A Barkan; M Molitch; A B Grossman; D Kleinberg; D Clemmons; P Chanson; E Laws; J Schlechte; M L Vance; K Ho; A Giustina
Journal:  J Clin Endocrinol Metab       Date:  2009-02-10       Impact factor: 5.958

9.  Assessment of cardiac autonomic functions by heart rate recovery, heart rate variability and QT dynamicity parameters in patients with acromegaly.

Authors:  Muhammet Dural; Giray Kabakcı; Neşe Cınar; Tomris Erbaş; Uğur Canpolat; Kadri Murat Gürses; Lale Tokgözoğlu; Ali Oto; Ergün Barış Kaya; Hikmet Yorgun; Levent Sahiner; Selçuk Dağdelen; Kudret Aytemir
Journal:  Pituitary       Date:  2014-04       Impact factor: 4.107

Review 10.  Updates in Diagnosis and Treatment of Acromegaly.

Authors:  Roula Zahr; Maria Fleseriu
Journal:  Eur Endocrinol       Date:  2018-09-10
View more
  3 in total

1.  Severe chronic periodontitis is not common in Acromegaly: Potential protective role of gingival BMP-2

Authors:  Sibel Başçıl; Özlem Turhan İyidir; Nilüfer Bayraktar; Melek Eda Ertörer; Neslihan Başçıl Tütüncü
Journal:  Turk J Med Sci       Date:  2021-06-28       Impact factor: 0.973

2.  Assessment of oro-dental manifestations in a series of acromegalic patients, the AcroDent study.

Authors:  Sylvain Roumeau; Joannice Thevenon; Lemlih Ouchchane; Salwan Maqdasy; Marie Batisse-Lignier; Christian Duale; Nathalie Pham Dang; Philippe Caron; Igor Tauveron; Laurent Devoize
Journal:  Endocr Connect       Date:  2020-08       Impact factor: 3.335

3.  Impact of concurrent diabetes on periodontal health in patients with acromegaly.

Authors:  Akanksha Jain; Shipra Gupta; Anil Bhansali; Mili Gupta; Ashish Jain; Nandini Bhaskar; Rose Kanwaljeet Kaur
Journal:  Sci Rep       Date:  2020-11-05       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.